Overtesting and overtreatment: the role of tracheal aspirate cultures in the diagnosis and management of ventilator-associated infections.

B. Morrow

DOI: https://doi.org/10.1097/PCC.0000000000000216

2014-10-01

Pediatric Critical Care Medicine

Abstract:

What problem does this paper attempt to address?

Microbiological Analysis of Endotracheal Aspirate and Endotracheal Tube Cultures in Mechanically Ventilated Patients.

Lijuan Shen,Fei Wang,Junfeng Shi,Weixin Xu,Tingting Jiang,Huifang Tang,Xiuwen Yu,Hao Yin,Shanyou Hu,Xiao Wu,Siu Kit Chan,Jie Sun,Qing Chang

DOI: https://doi.org/10.1186/s12890-019-0926-3

IF: 3.1

2019-01-01

BMC Pulmonary Medicine

Abstract:To compare the microbiological culture within endotracheal aspirate specimens (ETAs) and endotracheal tube specimens (ETTs) in patients undergoing mechanical ventilation (MV) by statistical tools. ETAs and ETTs from a total number of 81 patients, who were undergoing MV at the intensive care unit (ICU) of Jiading Central Hospital Affiliated Shanghai University of Medicine & Health Sciences from September 1st, 2017 to August 31st, 2018, were collected for microbiological culture analysis. Correlation of ETAs and ETTs cultures were obtained by Spear-men correlation analysis, while the consistency of the two specimens was determined by Kappa analysis and principal component analysis (PCA). Microbiological culture from both ETAs and ETTs showed that Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, and Klebsiella pneumoniae were the main pathogens, with Spear-man correlation coefficients of 0.676, 0.951, 0.730 and 0.687 respectively (all P < 0.01), and the overall Spear-man correlation coefficient is 0.757 (P < 0.01). This result shows that two samples were positively correlated. Kappa analysis also revealed high consistency of the microbial culture results from the ETAs and the ETTs (overall κ = 0.751, P < 0.01). The κ values for the four bacteria detected were 0.670, 0.949, 0.723, and 0.687, respectively (all P < 0.001). PCA also revealed high similarity. Combining microbiological culture and statistical analysis of samples collected from 81 patients who were undergoing MV in ICU, we showed that microbe found in the ETAs had high similarity with that found in the ETTs which collected at the end of the catheters. In clinical practice, ETAs analysis is easily accessible meanwhile provides a valuable information for MV patients.
Impact Clinically Related Factors on the Outcomes of Ventilator-Associated Pneumonia

Pan Zhou,Hong He,Jing-dong Liu,Xiao-hong Wu

DOI: https://doi.org/10.3760/j.issn:0254-6450.2003.03.015

2003-01-01

Abstract:OBJECTIVE:To define the influence clinically related factors in the prognosis of ventilated pneumonia (VAP).METHODS:A prospective clinical study involving 120 patients with VAP was carried ont. Etiologic diagnosis was established under quantitative culture of endotracheal aspiration, a protected specimen brush and bronchoalveolar lavage. Prognostic using a statistical software package (SPSS) factors were examined for univariate and multivariate analyses.RESULTS:Case fatality directly related to the infection was 14 percent. From univariate analysis, variables that significantly associated with attributable mortality were age older than 45 years, use of corticosteroids, presence of shock, in-hospital days of VAP over as follows 9, antecedent chronic obstructive pulmonary disease, and a prior antibiotic use. Through step-forward logistic regression analysis, only prior antibiotic use (P < 0.000 1, OR = 9.2) was defined as a significant factor influencing the risk of death from VAP. The same result was obtained when severity was included in the model. However, prior antibiotic use entirely dropped out as a significant risk factor when the etiologic agent was included in the regression equation.CONCLUSIONS:Distribution of microorganisms that responsible for VAP shown different in patients who had received prior antimicrobial therapy, and this factor caused higher mortality rate. We suggested a restrictive antibiotic use strategy among mechanically ventilated patients to reduce the risk of death from VAP.
Microbial Investigations in Throat Swab and Tracheal Aspirate Specimens Are Beneficial to Predict the Corresponding Endotracheal Tube Biofilm Flora among Intubated Neonates with Ventilator-Associated Pneumonia

Yun Pan,Lizhong Du,Qing Ai,Sijie Song,Xiaoli Tang,Danping Zhu,Jialin Yu

DOI: https://doi.org/10.3892/etm.2017.4631

IF: 2.7

2017-01-01

Experimental and Therapeutic Medicine

Abstract:Ventilator-associated pneumonia (VAP) is a common nosocomial infection in neonatal intensive care units with high morbidity and mortality. Bacterial biofilm in the endotracheal tube (ET) provides a notable and persistent source of pathogens that may cause VAP, and thus is important for VAP detection. However, during intubation microbial investigations in ET, samples are unavailable due to the infeasibility of collecting ET samples during intubation of neonates. It is therefore of great importance to find alternative sources of samples that can help identify the ET biofilm flora. In the present study, the microbial signatures of throat swabs and tracheal aspirates were compared with ET biofilm samples from VAP neonates using 16S ribosomal RNA gene polymerase chain reaction, denaturing gradient gel electrophoresis (DGGE), cloning and sequencing. Sequences were assigned to phylogenetic species using BLAST. Microbial diversity and richness among the three types of specimens were compared based on their DGGE fingerprints, and taxonomic characteristics based on the BLAST results. The microbial richness and diversity of ET biofilms were similar to tracheal aspirate yet significantly different from throat swab samples (P<0.05). Compared with ET biofilms, the overall constituent ratio of microflora was significantly different in throat swab and tracheal aspirate samples (P<0.05). However tracheal aspirate samples were useful for predicting Staphylococcus sp. in ET biofilms with a sensitivity of 85.7% and a specificity of 83.3%. The sensitivity for the combination of tracheal aspirate and throat swab samples to detect Staphylococcus sp. in ET biofilms was 100%. The detection of Pseudomonas sp. in throat swabs assisted its identification in ET biofilms (sensitivity 33.3% and specificity 100%). The results of the present study suggest that microbial investigations in throat swab and tracheal aspirate samples are beneficial for identifying the ET biofilm flora. There may therefore be clinical applications of using substituent samples to identify pathogens in ET biofilms for VAP surveillance among intubated neonates.
Patient factors associated with positive respiratory cultures following tracheostomy in pediatric patients

Ashley L Miller,Catherine K Hart,Derek D Kao,Laura E Bellew,Erik B Hysinger

DOI: https://doi.org/10.1016/j.ijporl.2024.112075

Abstract:Objectives: An increasing number of pediatric patients undergo tracheostomy placement annually. Despite advances in care, these patients remain at high risk for postoperative complications, including respiratory infections. The risk factors for positive respiratory cultures and the impact of culture positivity on overall morbidity and mortality in this population is not fully characterized. Study design and setting: Retrospective cross-sectional analysis of all patients within a single tertiary care institution who underwent tracheostomy placement from January 1, 2019 to 12/31/2021. Methods: We collected patient demographic information, comorbidities, primary indication for tracheostomy placement, and respiratory culture information preoperatively and postoperatively. The primary outcome measure was positive bacterial respiratory culture with speciation within 1, 3, or 6 months of tracheostomy placement. The secondary outcome measure was all-cause mortality within the study period. Results: A total of 180 patients with median (IQR) age of 5.2 (3.4-31.0) months at time of tracheostomy placement were included in the study. Nearly half of patients had a positive culture within 1 month (n = 81,47.4 %) while 63.7 % of patients were positive within 6 months of tracheostomy placement (n = 109). Risk factors included respiratory and/or cardiac comorbidities. Positive respiratory cultures within 6 months of surgery and cardiac and/or neurologic comorbidities were associated with increased all-cause mortality following tracheostomy placement. Conclusions: Positive respiratory cultures are common following tracheostomy placement, more so in patients with cardiac and pulmonary comorbid conditions. Positive cultures are associated with increased all-cause mortality. More work is necessary to determine optimal screening frequency and treatment protocols for positive cultures in this population.
Visiting Mom: A pilot evaluation of a prison-based visiting program serving incarcerated mothers and their minor children

Erin C Schubert,Megan Duininck,Rebecca J. Shlafer

DOI: https://doi.org/10.1080/10509674.2016.1159641

2016-04-11

Journal of Offender Rehabilitation

Abstract:ABSTRACT We describe an evaluation of a prison-visiting program, Extended Visiting (EV), for incarcerated mothers and their children. Mothers (N = 24) and caregivers (N = 19) were interviewed regarding experiences with the program. Mothers identified benefits including maintaining a relationship with children, physical contact, motivation, privacy, peer support, and personal growth. Caregivers echoed mothers’ appreciation for the opportunity to maintain mother–child relationships and physical contact. Mothers identified barriers including desire for overnight visits and more age-appropriate activities. Caregivers perceived travel time and costs and children’s adverse reactions as barriers. When comparing EV to typical visiting, participants unanimously preferred EV.
Analysis of the risk factors and pathogenic bacteria of ventilator-associated pneumonia

Ren-hui CHEN,Fu-zheng TAO,Ying-zi CHEN,Jun-qing WANG,Xi CHEN

DOI: https://doi.org/10.11816/cn.ni.2014-143823

2014-01-01

Abstract:OBJECTIVE To explore the risk factors of ventilator‐associated pneumonia and the distribution of the related pathogens ,so as to provide scientific evidence for the prevention and control of ventilator associated pneu‐monia. METHODS A retrospective analysis was conducted to 172 patients who were treated with mechanical venti‐lation in ICU from Feb. 2012 to Feb. 2014. The clinical features ,risk factors and the distribution of pathogens related to ventilator‐associated pneumonia were studied. All data were analyzed by SPSS 11. 0. RESULTS In 172 patients who were treated with mechanical ventilation ,78 were infected with ventilator‐associated pneumonia ,the incidence rate was 45. 35%. The sputum specimens of them were examined and 105 strains of pathogenic bacteria were found. Of them ,62 strains were gram‐negative bacilli ,accounting for 59. 05%. 27 strains were gram‐posi‐tive bacilli ,accounting for 25. 71%. 16 strains were fungi ,accounting for 15. 24%. The risk factors of ventilator‐associated pneumonia included age ,underlying diseases ,mechanical ventilation time ,and the existence of con‐sciousness disorder , tracheotomy , invasive operation , antibiotic application and duration of hospitalization. CONCLUSION There are many risk factors for ICU patients with ventilator‐associated pneumonia so we call for a strict ventilation index ,which can provide the corresponding nursing measures considering these risk factors. Strict implementation of aseptic management ,precaution of reflux and aspiration ,and rational use of antimicrobial drugs ,can effectively reduce the incidence of ventilator‐associated pneumonia.
Association of Endotracheal Aspirate Culture Variability and Antibiotic Use in Mechanically Ventilated Pediatric Patients

Andrea Prinzi,Sarah K Parker,Cary Thurm,Meghan Birkholz,Anna Sick-Samuels

DOI: https://doi.org/10.1001/jamanetworkopen.2021.40378

2021-12-01

Abstract:Importance: Endotracheal aspirate cultures are commonly collected from patients with mechanical ventilation to evaluate for ventilator-associated pneumonia or tracheitis. However, the respiratory tract is not sterile, making differentiating between colonization from bacterial infection challenging, and results may be unreliable owing to variable specimen quality and sample processing across laboratories. Despite these limitations, clinicians routinely interpret bacterial growth in endotracheal aspirate cultures as evidence of infection, sometimes regardless of organism significance, prompting antibiotic treatment. Objective: To assess the variability in endotracheal aspirate culture rates and the association between culture rates and antibiotic prescribing among patients with mechanical ventilation across children's hospitals in the US. Design, setting, and participants: Cross-sectional retrospective analysis of data obtained from the Children's Hospital Association Pediatric Health Information System database between January 1, 2016, through December 31, 2019. Participants were all patients hospitalized with mechanical ventilation aged less than 18 years. Exposures: A charge for an endotracheal aspirate culture on a ventilated day. Main outcomes and measures: Endotracheal aspirate culture rate and antibiotic days of therapy per ventilated days. For mechanical ventilation, clinical transaction classification codes for mechanical ventilation other unspecified ventilator assistance were used. To identify respiratory cultures, the laboratory test code for aerobic culture was used and relevant keywords (ie, respiratory tract, sputum) were used to identify sources in the hospital charge description master. Results: A total of 152 132 patients were identified among 31 hospitals. Among these patients, 79 691 endotracheal aspirate cultures were collected on a ventilator-day (patients aged less than 1 year, 44%; 1-4 years, 27%, 5-11 years. 16%, and 12-18 years, 13%; 3% were Asian; 17% Hispanic; 21% non-Hispanic Black; 45% Non-Hispanic White patients; 14% were other; 56% of patients were male, 44% were female). The overall median rate of culture use was 46 per 1000 ventilator-days (IQR, 32-73 cultures per 1000 ventilator-days). The endotracheal aspirate culture rate was positively correlated with the hospital's antibiotic days of therapy rate (R = 0.46; P = .009). In a multivariable model adjusting for patient-level and hospital-level characteristics and among patients with mechanical ventilation, each additional endotracheal aspirate culture was associated with 2.87 (95% CI, 2.74-3.01) higher odds of receiving additional days of therapy compared with patients who did not receive and endotracheal aspirate culture. Conclusions and relevance: In this study, notable variability was found in endotracheal aspirate culture rates across US pediatric hospitals and pediatric intensive care units, and endotracheal aspirate culture use was associated with increased antibiotic use. These findings suggest an opportunity for diagnostic and antibiotic stewardship to standardize testing and treatment of suspected ventilator-associated infections in pediatric patients with mechanical ventilation pediatric patients.
Comparison of Outcomes Between Early and Late Tracheostomy.

Jiaqi Luo,Wenfeng Xie,Shuyi Hong,Jinliang Gao,Chunhua Yang,Yiming Shi

DOI: https://doi.org/10.4187/respcare.10837

2023-01-01

Respiratory Care

Abstract:BACKGROUND:The timing of tracheostomy in ventilated patients remains controversial. This study aimed to compare the effect of early tracheostomy (≤7 d) with late tracheostomy (>7 d) on the prognosis of patients requiring prolonged mechanical ventilation.METHODS:This was a retrospective observational cohort study. The data of 175 patients who received tracheostomy at the ICU between January 1, 2015-July 31, 2022, were collected. Patients were excluded from the study if medical records were incomplete or they underwent tracheostomy as part of a planned operation procedure. One-to-one propensity score matching was used to correct the baseline characteristics between the early and late tracheostomy groups. The treatment process and outcomes were compared between the two groups. The primary outcome was the incidence of ventilator-associated pneumonia (VAP) between groups.RESULTS:After propensity score matching, 88 subjects were included in the analysis. Compared with the late tracheostomy group, the incidence of VAP, hospital length of stay, sedation-free days, ventilator-free days, and ICU-free days were longer in the early tracheostomy group. There were no significant differences in the 90-d mortality between the two groups. CONCLUSIONS;: Early tracheostomy can reduce the occurrence of complications for ICU patients.
New Therapeutic Challenges in Autoimmune Diseases

E. Choi

DOI: https://doi.org/10.5772/48207

2012-07-25

Abstract:The immune system is the body’s main line of defense against invasion by infectious organisms, such as bacteria, virus, and fungi. In normal immune systems, an immune response does not occur against the self-antigen, and is called self-tolerance. Autoimmune diseases occur when body tissues are attacked by the body’s own immune system due to loss of tolerance to self-antigens (Dejaco et al., 2006). Under these conditions, body tissues are destroyed by antigen-specific cytotoxic T cells or auto-antibodies, and the accompanying inflammation can cause functional disability and morbidity. Autoimmune diseases are a heterogenous group of diseases with a wide spectrum of symptoms that affect approximately 6% of the population (Siatskas et al., 2006). They can be broadly classified as organ-specific or systemic depending on the location of the target antigen and clinical features (Sakaguchi, 2000). Common examples of systemic autoimmune diseases include systemic lupus erythematosus (SLE), rheumatoid arthritis, systemic sclerosis, ankylosing spondylitis, and polymyositis; examples of organ-specific autoimmune diseases include type 1 diabetes, Addison’s disease, Hashimoto thyroiditis, Graves’ disease, Sjogren's syndrome, vitiligo, pernicious anemia, glomerulonephritis, myasthenia gravis, Goodpasture’s syndrome, autoimmune hemolytic anemia, idiopathic thrombocytopenia purpura, and pulmonary fibrosis. The clinical features of autoimmune diseases are very different, but immunemediated mechanisms are associated with the generation of an adaptive immune response toward the target antigen (Kuby, 1994; Siatskas et al., 2006).
ARTERIOVENOUS ANEURYSM OF THE RETINA

E. Gregersen

DOI: https://doi.org/10.1111/j.1755-3768.1961.tb07759.x

1961-10-01

Acta Ophthalmologica

Abstract:By now the ophthalmological literature contains almost fifty cases of retinal arteriovenous aneurysms, also called racemose haemangioma. In Scandinavia the first cases were reported by Gertz (1916), Ehlers (1924), and Frandsen (1950). Recently, Bech & Jensen (1958) published two cases. Reviews of the literature may be found in the papers of Bech & Jensen and Rundles & Falls (1 95 1). The case to be reported below is rather exceptional in having undergone spontaneous thrombosis and a kind of ,,healing<<. A brief description would, therefore, appear to be of interest. The patient was a male, now aged 46 (Case rec. 201/60, Eye Department, Copenhagen City Hospital), in good health apart from the eye disease, and with no history of earlier ocular complaints. About 4 years previously, when the patient was being fitted with spectacles, a large arteriovenous aneurysm was detected in the right eye, above the disc (cf. Fig. 1). At that time it was silent, and it was not photographed. I t presented itself as a big, thick, and distended vessel in which the venous and arterial blood could be seen mixing in layers. The eye was intact and its functions normal. About a year ago the patient developed acute visual impairment in the right eye (<6/36). Ophthalmoscopy revealed that the area of the arteriovenous anastomosis was the seat of large haemorrhages and exudates concealing the morphology of the anastomosis (cf. Fig. 2 ) . The ophthalmoscopic appearances had to be interpreted as thrombosis of the aneurysmal vessels. Within about six months, the haemorrhages and exudates were spontaneously absorbed. Ophthalmoscopy of the right eye now showed >>healing<< of the aneurysm, its calibre having perceptibly decreased so that in places its lumen
The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here?

Lucy B. Palmer,Gerald C. Smaldone

DOI: https://doi.org/10.1089/jamp.2021.0023

2022-02-01

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Abstract:Respiratory infection is common in intubated/tracheotomized patients and systemic antibiotic therapy is often unrewarding. In 1967, the difficulty in treating Gram-negative respiratory infections led to the use of inhaled gentamicin, targeting therapy directly to the lungs. Fifty-three years later, the effects of topical therapy in the intubated patient remain undefined. Clinical failures with intravenous antibiotics persist and instrumented patients are now infected by many more multidrug-resistant Gram-negative species as well as methicillin-resistant <i>Staphylococcus aureus</i>. Multiple systematic reviews and meta-analyses suggest that there may be a role for inhaled delivery but "more research is needed." Yet there is still no Food and Drug Administration (FDA) approved inhaled antibiotic for the treatment of ventilator-associated infection, the hallmark of which is the foreign body in the upper airway. Current pulmonary and infectious disease guidelines suggest using aerosols only in the setting of Gram-negative infections that are resistant to all systemic antibiotics or not to use them at all. Recently two seemingly well-designed large randomized placebo-controlled Phase 2 and Phase 3 clinical trials of adjunctive inhaled therapy for the treatment of ventilator-associated pneumonia failed to show more rapid resolution of pneumonia symptoms or effect on mortality. Despite evolving technology of delivery devices and more detailed understanding of the factors affecting delivery, treatment effects were no better than placebo. What is wrong with our approach to ventilator- associated infection? Is there a message from the large meta-analyses and these two large recent multisite trials? This review will suggest why current therapies are unpredictable and have not fulfilled the promise of better outcomes. Data suggest that future studies of inhaled therapy, in the milieu of worsening bacterial resistance, require new approaches with completely different indications and endpoints to determine whether inhaled therapy indeed has an important role in the treatment of ventilated patients.

respiratory system
Factors associated with tracheostomy‐associated infection treatment: A multicenter observational study

John M. Morrison,Naoko Kono,Margaret Rush,Andrea Hahn,Catherine S. Forster,Jonathan D. Cogen,Joanna Thomson,Sarah Hofman DeYoung,Sowgand Bashiri,Wendy J. Mack,Michael N. Neely,Tamara D. Simon,Christopher J. Russell,for the Pediatric Research in Inpatient Settings Network

DOI: https://doi.org/10.1002/ppul.27117

IF: 4.0899

2024-06-12

Pediatric Pulmonology

Abstract:Objective To characterize factors that influence the decision to treat suspected pediatric bacterial tracheostomy‐associated respiratory infections (bTRAINs; e.g., pneumonia, tracheitis). Methods We conducted a multicenter, prospective cohort study of children with pre‐existing tracheostomy hospitalized at six children's hospitals for a suspected bTRAIN (receipt of respiratory culture plus ≥1 doses of an antibiotic within 48 h). The primary predictor was respiratory culture growth categorized as Pseudomonas aeruginosa, P. aeruginosa + ≥1 other bacterium, other bacteria alone, or normal flora/no growth. Our primary outcome was bTRAIN treatment with a complete course of antibiotics as documented by the discharge team. We used logistic regression with generalized estimating equations to identify the association between our primary predictor and outcome and to identify demographic, clinical, and diagnostic testing factors associated with treatment. Results Of the 440 admissions among 289 patients meeting inclusion criteria, 307 (69.8%) had positive respiratory culture growth. Overall, 237 (53.9%) of admissions resulted in bTRAIN treatment. Relative to a negative culture, a culture positive for P. aeruginosa plus ≥1 other organism (adjusted odds ratio [aOR] 2.3; 95% confidence interval [CI] 1.02–5.0)] or ≥1 other organism alone (aOR: 2.8; 95% CI: 1.4–5.6)] was associated with treatment. Several clinical and diagnostic testing (respiratory Gram‐stain and chest radiograph) findings were also associated with treatment. Positive respiratory viral testing was associated with reduced odds of treatment (aOR: 0.5; 95% CI: 0.2–0.9). Conclusions Positive respiratory cultures as well as clinical indicators of acute illness and nonculture test results were associated with bTRAIN treatment. Clinicians may be more comfortable withholding antibiotics when a virus is identified during testing.

pediatrics,respiratory system
Features Associated With the Presence of Specific Bacterial Strains in Pediatric Tracheostomy

Caseng Zhang,Dalia Elawad,Matthew S Hicks,Cathy Schellenberg,Carina Majaesic,Gregory Tyrrell,E Anne Hicks

DOI: https://doi.org/10.4187/respcare.11733

2024-10-22

Abstract:Background: Tracheostomy bypasses physical barriers that decrease microbial access to the lower airway, which can lead to changes to the lung microbiota. Patients often become chronically colonized with potential pathogens. This study described the incidence and prevalence of specific organisms in a 5-y cohort of children with tracheostomy. Methods: This retrospective cohort of children aged 0-18 y with tracheostomy identified associations between microbial species and subject characteristics including reason for tracheostomy, gastrostomy tube (G-tube), fundoplication, and ventilator use using chi-square test or Fisher exact test. Results: Of 113 eligible patients, 79 (57% male) met study inclusion criteria. Reasons for tracheostomy included airway obstruction secondary to craniofacial anomalies in 16 children (20%), upper-airway obstruction in 14 subjects (17.3%), neuromuscular disorder in 19 subjects (24%), bronchopulmonary dysplasia with or without pulmonary hypertension in 17 subjects (21%), and congenital heart disease in 13 subjects (16%). Most (69%) used a ventilator for at least 6 h/d; 63% had a G-tube; 41% also had a Nissen fundoplication. Of the 20% with upper-airway obstruction, one third were ventilator dependent, unlike other diagnoses where 57% used a ventilator. Staphylococcus aureus (52/113), Pseudomonas aeruginosa (43/113), and Stenotrophomonas species (39/113) were the most frequently identified bacterial species. Most microbes identified were not associated with subjects underlying diagnoses, ventilator use, or feeding type. However, there was a significant association between upper-airway obstruction and group B Streptococcus species and G-tube with P. aeruginosa. Conclusions: This retrospective single-site descriptive cohort analysis of pediatric subjects with long-term tracheostomy identified trends in microbial prevalence. The presence of specific bacterial strains was more likely to follow individual subject trajectories than sequential appearance of species. P. aeruginosa was associated with G-tube and Streptococcus species with upper-airway obstruction. Ventilator dependence was not associated with specific microbial profiles.
Current Concepts in Community and Ventilator Associated Lower Respiratory Tract Infections in ICU Patients

Ignacio Martin-Loeches

DOI: https://doi.org/10.3390/antibiotics9070380

2020-07-05

Antibiotics

Abstract:It is widely known that pneumonia (either community acquired or hospital acquired, as like ventilator associated pneumonia (VAP)), is the most frequent type of severe infection and continues to pose a significant burden on healthcare services worldwide. Despite new diagnostic developments, most pneumonia cases continue to be difficult to diagnose clinically, partly due to acquired antibiotic resistance and the lack of a ‘gold standard’ method of diagnosis. In other words, the lack of a rapid, accurate diagnostic test, as well as the uncertainty of the initial etiologic diagnosis and the risk stratification, results in empirical antibiotic treatments. There are significant changes in the aetiology of patients with ventilator associated lower respiratory tract infections (VA-LRTI), which are characterised by a higher incidence of multi drug resistant organisms. Evidence suggests that when patients with VA-LRTI develop organ failure, the associated mortality can be exceptionally high with frequent complications, including acute respiratory distress syndrome, acute kidney injury, and septic shock. Appropriate antibiotic treatments must consider that the present cardiovascular failure seen in patients has a different association with the patient’s mortality. Unlike patients with less severe clinical presentations, who have a higher chance of survival when the appropriate antibiotics are administered promptly, for patients with a severe subtype of the disease, the appropriateness of antibiotic treatment will impact the patient’s outcome to a lesser extent. The present review highlights certain factors detectable at the time of admission that could indicate patients who are at a high risk of bacteraemia and who, therefore, merit more intense therapy and stratified care.
[On the analysis of p-aminomethylbenzoic acid (PAMBA), a new antifibrinolytic].

H. Klöcking,F. Markwardt,M. Richter

1965-09-01

Pharmazie

Abstract:
Therapy of Aspiration: Out-of-Hospital and In-Hospital-Acquired

Di Pan,Bradley Isaacs,Michael S. Niederman

DOI: https://doi.org/10.1055/s-0044-1791826

2024-10-26

Seminars in Respiratory and Critical Care Medicine

Abstract:Therapeutic considerations for aspiration pneumonia prioritize the risk of multidrug-resistant organisms. This involves integrating microbiological insights with each patient's unique risk profile, including the location at the time of aspiration, and whether it occurred in or out of the hospital. Our understanding of the microbiology of aspiration pneumonia has also evolved, leading to a reassessment of anaerobic bacteria as the primary pathogens. Emerging research shows a predominance of aerobic pathogens, in both community and hospital-acquired cases. This shift challenges the routine use of broad-spectrum antibiotics targeting anaerobes, which can contribute to antibiotic resistance and complications such as Clostridium difficile infections—concerns that are especially relevant given the growing issue of antimicrobial resistance. Adopting a comprehensive, patient-specific approach that incorporates these insights can optimize antibiotic selection, improve treatment outcomes, and reduce the risk of resistance and adverse effects. Article published online: 25 October 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

respiratory system,critical care medicine
Molecular analysis of microbial communities in endotracheal tube biofilms

Scott Cairns,John Gilbert Thomas,Samuel James Hooper,Matthew Peter Wise,Paul John Frost,Melanie Julia Wilson,Michael Alexander Oxenham Lewis,David Wynne Williams

DOI: https://doi.org/10.1371/journal.pone.0014759

IF: 3.7

2011-03-14

PLoS ONE

Abstract:Background: Ventilator-associated pneumonia is the most prevalent acquired infection of patients on intensive care units and is associated with considerable morbidity and mortality. Evidence suggests that an improved understanding of the composition of the biofilm communities that form on endotracheal tubes may result in the development of improved preventative strategies for ventilator-associated pneumonia. Methodology/principal findings: The aim of this study was to characterise microbial biofilms on the inner luminal surface of extubated endotracheal tubes from ICU patients using PCR and molecular profiling. Twenty-four endotracheal tubes were obtained from twenty mechanically ventilated patients. Denaturing gradient gel electrophoresis (DGGE) profiling of 16S rRNA gene amplicons was used to assess the diversity of the bacterial population, together with species specific PCR of key marker oral microorganisms and a quantitative assessment of culturable aerobic bacteria. Analysis of culturable aerobic bacteria revealed a range of colonisation from no growth to 2.1×10(8) colony forming units (cfu)/cm(2) of endotracheal tube (mean 1.4×10(7) cfu/cm(2)). PCR targeting of specific bacterial species detected the oral bacteria Streptococcus mutans (n = 5) and Porphyromonas gingivalis (n = 5). DGGE profiling of the endotracheal biofilms revealed complex banding patterns containing between 3 and 22 (mean 6) bands per tube, thus demonstrating the marked complexity of the constituent biofilms. Significant inter-patient diversity was evident. The number of DGGE bands detected was not related to total viable microbial counts or the duration of intubation. Conclusions/significance: Molecular profiling using DGGE demonstrated considerable biofilm compositional complexity and inter-patient diversity and provides a rapid method for the further study of biofilm composition in longitudinal and interventional studies. The presence of oral microorganisms in endotracheal tube biofilms suggests that these may be important in biofilm development and may provide a therapeutic target for the prevention of ventilator-associated pneumonia.
Ventilator-associated events: From surveillance to optimizing management

Sergio Ramirez-Estrada,Yolanda Peña-Lopez,Tarsila Vieceli,Jordi Rello

DOI: https://doi.org/10.1016/j.jointm.2022.09.004

2022-11-12

Abstract:Mechanical ventilation (MV) is a life-support therapy that may predispose to morbid and lethal complications, with ventilator-associated pneumonia (VAP) being the most prevalent. In 2013, the Center for Disease Control (CDC) defined criteria for ventilator-associated events (VAE). Ten years later, a growing number of studies assessing or validating its clinical applicability and the potential benefits of its inclusion have been published. Surveillance with VAE criteria is retrospective and the focus is often on a subset of patients with higher than lower severity. To date, it is estimated that around 30% of ventilated patients in the intensive care unit (ICU) develop VAE. While surveillance enhances the detection of infectious and non-infectious MV-related complications that are severe enough to impact the patient's outcomes, there are still many gaps in its classification and management. In this review, we provide an update by discussing VAE etiologies, epidemiology, and classification. Preventive strategies on optimizing ventilation, sedative and neuromuscular blockade therapy, and restrictive fluid management are warranted. An ideal VAE bundle is likely to minimize the period of intubation. We believe that it is time to progress from just surveillance to clinical care. Therefore, with this review, we have aimed to provide a roadmap for future research on the subject.
Respiratory microbiome in mechanically ventilated patients: a narrative review

Mélanie Fromentin,Jean-Damien Ricard,Damien Roux

DOI: https://doi.org/10.1007/s00134-020-06338-2

Abstract:The respiratory microbiome has been less explored than the gut microbiome. Despite the speculated importance of dysbiosis of the microbiome in ventilator-associated pneumonia (VAP) and acute respiratory distress syndrome (ARDS), only few studies have been performed in invasively ventilated ICU patients. And only the results of small cohorts have been published. An overlap exists between bacterial populations observed in the lower respiratory tract and the oropharyngeal tract. The bacterial microbiota is characterized by relatively abundant bacteria difficult to cultivate by standard methods. Under mechanical ventilation, a dysbiosis occurs with a drop overtime in diversity. During VAP development, lung dysbiosis is characterized by a shift towards a dominant bacterial pathogen (mostly Proteobacteria) whereas enrichment of gut-associated bacteria mainly Enterobacteriaceae is the specific feature discriminating ARDS patients. However, the role of this dysbiosis in VAP and ARDS pathogenesis is not yet fully understood. A more in-depth analysis of the interplay between bacteria, virus and fungi and a better understanding of the host-microbiome interaction could provide a more comprehensive view of the role of the microbiome in VAP and ARDS pathogenesis. Priority should be given to validate a consensual and robust methodology for respiratory microbiome research and to conduct longitudinal studies. A deeper understanding of microbial interplay should be a valuable guide for care of ARDS and VAP preventive/therapeutic strategies. We present a review on the current knowledge and expose perspectives and potential clinical applications of respiratory microbiome research in mechanically ventilated patients.
Hot topics on the diagnosis and antimicrobial therapy of ventilator-associated pneumonia

Jing ZHANG,Jieming QU

DOI: https://doi.org/10.7507/1002-0179.201710185

2018-01-01

Abstract:Hot topics on the diagnosis and antimicrobial therapy of ventilator-associated pneumonia,including clinical diagnostic criteria,evaluation of biomarkers,ventilator associated events,clinical pulmonary infection score,ventilator-associated tracheobronchitis,microbiological diagnosis and duration of therapy were discussed.The viewpoints in the guidelines of America,Europe and Japan were also reviewed.

Overtesting and overtreatment: the role of tracheal aspirate cultures in the diagnosis and management of ventilator-associated infections.

Microbiological Analysis of Endotracheal Aspirate and Endotracheal Tube Cultures in Mechanically Ventilated Patients.

Impact Clinically Related Factors on the Outcomes of Ventilator-Associated Pneumonia

Microbial Investigations in Throat Swab and Tracheal Aspirate Specimens Are Beneficial to Predict the Corresponding Endotracheal Tube Biofilm Flora among Intubated Neonates with Ventilator-Associated Pneumonia

Patient factors associated with positive respiratory cultures following tracheostomy in pediatric patients

Visiting Mom: A pilot evaluation of a prison-based visiting program serving incarcerated mothers and their minor children

Analysis of the risk factors and pathogenic bacteria of ventilator-associated pneumonia

Association of Endotracheal Aspirate Culture Variability and Antibiotic Use in Mechanically Ventilated Pediatric Patients

Comparison of Outcomes Between Early and Late Tracheostomy.

New Therapeutic Challenges in Autoimmune Diseases

ARTERIOVENOUS ANEURYSM OF THE RETINA

The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here?

Factors associated with tracheostomy‐associated infection treatment: A multicenter observational study

Features Associated With the Presence of Specific Bacterial Strains in Pediatric Tracheostomy

Current Concepts in Community and Ventilator Associated Lower Respiratory Tract Infections in ICU Patients

[On the analysis of p-aminomethylbenzoic acid (PAMBA), a new antifibrinolytic].

Therapy of Aspiration: Out-of-Hospital and In-Hospital-Acquired

Molecular analysis of microbial communities in endotracheal tube biofilms

Ventilator-associated events: From surveillance to optimizing management

Respiratory microbiome in mechanically ventilated patients: a narrative review

Hot topics on the diagnosis and antimicrobial therapy of ventilator-associated pneumonia